Glenmark Investigational Site 1

New York, New York 10029

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Multiple Myeloma Clinical Trial
Study of GBR 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Glenmark Investigational Site 1
mi
from
New York, NY
Click here to add this to my saved trials